Dyslipidemia/Glucose Metabolism Disorder Clinical Trial
Official title:
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Low and Standard Doses of Fenofibrate in Combination With Metformin on the Lipid Profile in Patients With Type 2 Diabetes and Dyslipidemia.
The primary objective was to assess the effect of 3-month treatment of low and standard doses of fenofibrate in combination with stable dose of metformin on fasting triglycerides levels in patients with type 2 diabetes and dyslipidemia.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00362323 -
Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
|
Phase 3 | |
| Completed |
NCT00348725 -
Acceptability of a Fixed Combination of Fenofibrate and Metformin
|
Phase 3 |